The origins and consequences of obesity. Diabetes
- PMID: 9017275
The origins and consequences of obesity. Diabetes
Abstract
A relationship exists between obesity and non-insulin-dependent diabetes mellitus. Central, abdominal obesity carries a particularly high risk that is most likely associated with enlargement of visceral fat deposits. A multiple endocrine perturbation is associated with visceral obesity. This consists of a hypersensitive hypothalamic-pituitary-adrenal (HPA) axis, with resulting excess of cortisol secretion upon stimulation. Growth hormone levels in both sexes are diminished and testosterone concentrations in men are lower than normal. In women a moderate hyperandrogenism is often present. The elevated sensitivity of the HPA axis may be a primary event, followed by adrenal androgen production in women and by interaction at several levels, with inhibition of both the growth hormone and pituitary-gonadal axes. Together, these endocrine perturbations seem to be able to centralize body fat to visceral depots because of a high density of steroid hormone receptors. The endocrine perturbations are most likely followed by insulin resistance. Elevated cortisol levels, deficiencies in sex-specific steroid hormones and excess androgens result in insulin resistance. The endocrine abnormalities in visceral obesity are followed by insulin resistance, both directly and indirectly via contribution of excess free fatty acids from centralized body fat depots. The hyperactivity of the HPA axis may be due to frequent challenges and it is amplified by a deficient feedback inhibition. A depressive, helplessness reaction to stress may be involved. Such stress factors may be found in socioeconomic and psychosocial handicaps, as suggested by results of population studies. This hypothesis is strongly supported by the reproduction of an identical condition in non-human primates that react with a depressive reaction upon psychosocial types of stressors. The perturbations of the HPA axis may thus be in the centre of the syndrome. Studies of this axis in established non-insulin-dependent diabetes mellitus suggest similar perturbations, but the information is not conclusive.
Similar articles
-
Body fat distribution, insulin resistance, and metabolic diseases.Nutrition. 1997 Sep;13(9):795-803. doi: 10.1016/s0899-9007(97)00191-3. Nutrition. 1997. PMID: 9290093 Review.
-
Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes?Med Sci Monit. 2003 Feb;9(2):RA35-9. Med Sci Monit. 2003. PMID: 12601304 Review.
-
Stress and cardiovascular disease.Acta Physiol Scand Suppl. 1997;640:144-8. Acta Physiol Scand Suppl. 1997. PMID: 9401628 Review.
-
The regulation of adipose tissue distribution in humans.Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Int J Obes Relat Metab Disord. 1996. PMID: 8680455 Review.
-
Growth hormone and the metabolic syndrome.J Endocrinol Invest. 1999;22(5 Suppl):41-6. J Endocrinol Invest. 1999. PMID: 10442570 Review.
Cited by
-
Chronic subordination stress induces hyperphagia and disrupts eating behavior in mice modeling binge-eating-like disorder.Front Nutr. 2015;1(30):30. doi: 10.3389/fnut.2014.00030. Front Nutr. 2015. PMID: 25621284 Free PMC article.
-
Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome.Appl Clin Genet. 2014 Apr 1;7:43-53. doi: 10.2147/TACG.S39993. eCollection 2014. Appl Clin Genet. 2014. PMID: 24817815 Free PMC article. Review.
-
Sex and Age Differences in Association between Physical Activity and Metabolic Syndrome: Results from NHANES 2003-2006.Healthcare (Basel). 2023 Apr 7;11(8):1059. doi: 10.3390/healthcare11081059. Healthcare (Basel). 2023. PMID: 37107893 Free PMC article.
-
Racial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians.Curr Obes Rep. 2015 Jun;4(2):241-9. doi: 10.1007/s13679-015-0150-2. Curr Obes Rep. 2015. PMID: 26627219 Review.
-
Positive association between blood ethylene oxide levels and metabolic syndrome: NHANES 2013-2020.Front Endocrinol (Lausanne). 2024 Apr 18;15:1365658. doi: 10.3389/fendo.2024.1365658. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38699390 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical